Artwork

コンテンツは Labiotech によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Labiotech またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal
Player FM -ポッドキャストアプリ
Player FMアプリでオフラインにしPlayer FMう!

How does AI assist drug discovery?

38:26
 
シェア
 

Manage episode 401257192 series 3361449
コンテンツは Labiotech によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Labiotech またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal

Artificial intelligence (AI) is certainly in the news constantly; however, it’s been used in drug discovery for some time.

A new collaboration between artificial intelligence drug discovery company Insilico Medicine and University of Toronto biochemist and molecular geneticist Igor Stagljar will test AI-designed molecules against "undruggable" cancer targets.

The research will test 15 to 20 undruggable targets - but are they undruggable? And how does AI work in the drug discovery process?

This week, we have a conversation with Kyle Tretina, Alliance Manager of AI Platforms at Insilico Medicine, on a wide range of subjects including drug discovery, undruggable targets, the collaboration with the University of Toronto, and more.

00:58-05:11: About Insilico Medicine
05:11-06:09: Why is AI in the news?
06:09-07:39: Helping people through AI
07:39-09:10: What is Insilico Medicine doing with AI?
09:10-10:15: Does Insilico Medicine take drugs from idea to trials?
10:15-11:32: How do your partnerships come about?
11:32-19:34: How does drug development start with AI?
19:34-24:43: Can AI address undruggable targets?
24:43-25:05: What do you need to do after finding a potential drug?
25:05-27:57: Can quantum computing aid drug development?
27:57-30:13: How can AI help reduce costs and save time?
30:13-32:56: What is your partnership with the University of Toronto?
32:56-36:24: What is the timescale for introducing drugs from AI?
36:24-37:29: What conditions are you working on?

Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here!

Stay updated by subscribing to our newsletter

  continue reading

1. How does AI assist drug discovery? (00:00:00)

2. About Insilico Medicine (00:00:58)

3. Why is AI in the news? (00:05:11)

4. Helping people through AI
 (00:06:09)

5. What is Insilico Medicine doing with AI? (00:07:39)

6. Does Insilico Medicine take drugs from idea to trials?
 (00:09:10)

7. How do your partnerships come about? (00:10:15)

8. How does drug development start with AI?
 (00:11:32)

9. Can AI address undruggable targets? (00:19:34)

10. What do you need to do after finding a potential drug?
 (00:24:43)

11. Can quantum computing aid drug development?
 (00:25:05)

12. How can AI help reduce costs and save time? (00:27:57)

13. What is your partnership with the University of Toronto?
 (00:30:13)

14. What is the timescale for introducing drugs from AI?
 (00:32:56)

15. What conditions are you working on? (00:36:24)

125 つのエピソード

Artwork
iconシェア
 
Manage episode 401257192 series 3361449
コンテンツは Labiotech によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Labiotech またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal

Artificial intelligence (AI) is certainly in the news constantly; however, it’s been used in drug discovery for some time.

A new collaboration between artificial intelligence drug discovery company Insilico Medicine and University of Toronto biochemist and molecular geneticist Igor Stagljar will test AI-designed molecules against "undruggable" cancer targets.

The research will test 15 to 20 undruggable targets - but are they undruggable? And how does AI work in the drug discovery process?

This week, we have a conversation with Kyle Tretina, Alliance Manager of AI Platforms at Insilico Medicine, on a wide range of subjects including drug discovery, undruggable targets, the collaboration with the University of Toronto, and more.

00:58-05:11: About Insilico Medicine
05:11-06:09: Why is AI in the news?
06:09-07:39: Helping people through AI
07:39-09:10: What is Insilico Medicine doing with AI?
09:10-10:15: Does Insilico Medicine take drugs from idea to trials?
10:15-11:32: How do your partnerships come about?
11:32-19:34: How does drug development start with AI?
19:34-24:43: Can AI address undruggable targets?
24:43-25:05: What do you need to do after finding a potential drug?
25:05-27:57: Can quantum computing aid drug development?
27:57-30:13: How can AI help reduce costs and save time?
30:13-32:56: What is your partnership with the University of Toronto?
32:56-36:24: What is the timescale for introducing drugs from AI?
36:24-37:29: What conditions are you working on?

Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here!

Stay updated by subscribing to our newsletter

  continue reading

1. How does AI assist drug discovery? (00:00:00)

2. About Insilico Medicine (00:00:58)

3. Why is AI in the news? (00:05:11)

4. Helping people through AI
 (00:06:09)

5. What is Insilico Medicine doing with AI? (00:07:39)

6. Does Insilico Medicine take drugs from idea to trials?
 (00:09:10)

7. How do your partnerships come about? (00:10:15)

8. How does drug development start with AI?
 (00:11:32)

9. Can AI address undruggable targets? (00:19:34)

10. What do you need to do after finding a potential drug?
 (00:24:43)

11. Can quantum computing aid drug development?
 (00:25:05)

12. How can AI help reduce costs and save time? (00:27:57)

13. What is your partnership with the University of Toronto?
 (00:30:13)

14. What is the timescale for introducing drugs from AI?
 (00:32:56)

15. What conditions are you working on? (00:36:24)

125 つのエピソード

すべてのエピソード

×
 
Loading …

プレーヤーFMへようこそ!

Player FMは今からすぐに楽しめるために高品質のポッドキャストをウェブでスキャンしています。 これは最高のポッドキャストアプリで、Android、iPhone、そしてWebで動作します。 全ての端末で購読を同期するためにサインアップしてください。

 

クイックリファレンスガイド